Results 171 to 180 of about 13,707 (310)

Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study) [PDF]

, 2021
Wendy C. Moore, Oliver Kornmann, Marc Humbert, Claude Poirier, Elisabeth H. Bel, Norihiro Kaneko, Steven G. Smith, Neil Martin, M Gilson, Robert G. Price, Eric Bradford, Mark C. Liu   +11 more
openalex   +1 more source

Treatment of Eosinophilic Myositis with Mepolizumab

Indian Journal of Rheumatology, 2018
Farishta Waheed, Hafiz Muhammad Zubair, Saadia Waheed   +2 more
openaire   +3 more sources

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

Drug Design, Development and Therapy, 2017
Corrado Pelaia,1 Alessandro Vatrella,2 Maria Teresa Busceti,1 Luca Gallelli,3 Rosa Terracciano,3 Rocco Savino,3 Girolamo Pelaia1 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University “Magna Græcia&rdquo ...
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G   +6 more
doaj  

Faculty Opinions recommendation of Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.

, 2013
Anne Marie Irani, Santhosh Kumar
openalex   +2 more sources

IMPACT OF MEPOLIZUMAB IN PATIENTS WITH LIFE-THREATENING ASTHMA [PDF]

, 2020
Jared Silver, Michael Bogart, Néstor A. Molfino, Elizabeth R. Packnett, Donna McMorrow, Juan Wu, Beth Hahn   +6 more
openalex   +1 more source

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions [PDF]

, 2021
Peter G. Gibson, Charlene M. Prazma, Geoffrey Chupp, Eric Bradford, Mark Forshag, Stephen Mallett, Steve Yancey, Steven G. Smith, Elisabeth H. Bel   +8 more
openalex   +1 more source

Mepolizumab improves patient outcomes and reduces exacerbations in severe asthma patients with comorbid upper airways disease [PDF]

, 2019
Charlene M. Prazma, Frank C. Albers, Stephen Mallett, Jean-Pierre Llanos-Ackert, Steven W. Yancey   +4 more
openalex   +1 more source

Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody

, 2016
Karen Liao, Erik Meyer, Thomas N. Lee, Amy Loercher, Daniel J. Sikkema   +4 more
openalex   +1 more source

Mepolizumab does not alter blood basophil count in severe asthma [PDF]

, 2019
Adam Wright, Sarah Diver, Jamie McCarthy, Andrew Marvin, Marcia Soares, Tracy Thornton, Michelle Bourne, Michelle Craner, Helen Evans, Sarah Edwards, Sarah C. Glover, Liesl Carr, Sarah Parker, Salman Siddiqui, Dave Cousins, Christopher E. Brightling   +15 more
openalex   +1 more source

Therapeutic switch from omalizumab to mepolizumab in patients with uncontrolled severe eosinophilic asthma: treatment effect by exacerbations in previous year and maintenance use of OCS [PDF]

, 2020
Mark Liu, Bradley E. Chipps, Xavier Muñoz, Gilles Devouassoux, Miguel Bergna, Steven G. Smith, Frank C. Albers, Robert G. Price, Jay Azmi, Dmitri Galkin, Kenneth R. Chapman   +10 more
openalex   +1 more source